back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-26 10:34 Tx date 2025-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
7,500 | |
| Filed 2025-06-26 10:33 Tx date 2025-06-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
5,000 | |
| Filed 2025-06-26 10:25 Tx date 2025-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$64,500
+5,000 vol $12.90 each |
35,000 | |
| Filed 2025-06-26 10:24 Tx date 2025-06-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$63,800
+5,000 vol $12.76 each |
30,000 | |
| Filed 2023-06-30 15:07 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
2,500 | |
| Filed 2023-06-30 15:06 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-30 15:04 Tx date 2023-06-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$73,800
+20,000 vol $3.69 each |
25,000 | |
| Filed 2023-06-30 15:03 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,450
+5,000 vol $3.69 each |
5,000 | |
| Filed 2023-06-30 15:02 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|